Avandia Negatively Affects Cholesterol in HIV-Positive Patients

POZ - "People taking Avandia (rosiglitazone) to treat HIV-associated fat loss had unhealthy changes in cholesterol that can lead to heart problems, according to a study published in the November 30 issue of AIDS."